Recommended Pages at clincancerres.aacrjournals.org
A Patient Perspective on Brain Metastases in Breast Cancer
clincancerres.aacrjournals.org — “A Patient Perspective on Brain Metastases in Breast Cancer” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on February 2, 2012 at 4:12 pm By:
elaine schattner Oncologist, Hematologist, Physician, Doctor, and Internist
v @jodyms: "A Patient Perspective on Brain Metastases in Breast Cancer" by Musa Meyer - http://t.co/c34p0CxR
Ipilimumab: an Anti-CTLA-4 Antibody for Metastatic Melanoma
clincancerres.aacrjournals.org — “Ipilimumab: an Anti-CTLA-4 Antibody for Metastatic Melanoma” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on September 9, 2011 at 5:41 pm By:
Evan Lipson Oncology, Physician, Doctor, and Internist
A little review of ipilimumab for #melanoma: http://t.co/KQkcm9q
Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
clincancerres.aacrjournals.org — “Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on August 11, 2011 at 3:58 pm By:
Kidney Cancer Health Executive
Your doctor can access the Kidney Cancer Risk Score Calculator developed through this international project that... http://fb.me/18w5DMHit
Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma
clincancerres.aacrjournals.org — “Treatment-Induced Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on August 1, 2011 at 3:36 pm By:
Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive
Oxidative Stress and Cellular Antioxidant Capacity Determine Response to Bortezomib in Mantle Cell Lymphoma: http://t.co/KgA0JpF
Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
clincancerres.aacrjournals.org — “Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on June 17, 2011 at 9:40 pm By:
Foretinib inbits metastasis in ovarian cancer animal & invitro models http://t.co/A8eTW08
Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer
clincancerres.aacrjournals.org — “Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on June 1, 2011 at 11:37 pm By:
Diagnostic Biomarkers of Non small cell lung cancer in blood http://bit.ly/jHi3Et
New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine
clincancerres.aacrjournals.org — “New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on May 2, 2011 at 10:01 am By:
Matti Waananen, MD Surgeon, Neurosurgeon, Physician, and Doctor
New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine http://j.mp/jUOLcb
Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma --" Clin Cancer Res
clincancerres.aacrjournals.org — “Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma --" Clin Cancer Res” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on March 16, 2011 at 6:56 am By:
Matti Waananen, MD Surgeon, Neurosurgeon, Physician, and Doctor
Advances in the Biology and Treatment of Bone Disease in Multiple Myeloma http://j.mp/eFh5tB
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer
clincancerres.aacrjournals.org — “Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on February 5, 2011 at 2:49 am By:
Mark Robson Physician, Doctor, Internist, Oncologist, and Hematologist
Incidence and outcome of BRCA mutations in unselected patients with TNBC http://bit.ly/eO3bgf
Aldehyde Dehydrogenase 1--Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer --" Clin Cancer Res
clincancerres.aacrjournals.org — “Aldehyde Dehydrogenase 1--Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer --" Clin Cancer Res” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on February 3, 2011 at 6:28 am By:
Stathmin overexpression identifies high risk patients and lymph node metastasis in endometrial cancer --" Clin Cancer Res
clincancerres.aacrjournals.org — “Stathmin overexpression identifies high risk patients and lymph node metastasis in endometrial cancer --" Clin Cancer Res” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on February 2, 2011 at 8:54 pm By:
prognostic biomarker endometrial cancer #in http://clincancerres.aacrjournals.org/content/early/2011/01/26/1078-0432.CCR-10-2412.abstract
A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells " Clinical Cancer Research
clincancerres.aacrjournals.org — “A Novel FRET-Based Biosensor for the Measurement of BCR-ABL Activity and Its Response to Drugs in Living Cells " Clinical Cancer Research” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on July 31, 2010 at 11:10 am By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
New test to predicts resistance in CML http://ow.ly/2j6PQ
Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-acetic acid) to Docetaxel in CRMPC " Clinical Cancer Research
clincancerres.aacrjournals.org — “Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-acetic acid) to Docetaxel in CRMPC " Clinical Cancer Research” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on May 12, 2010 at 4:35 pm By:
Phase II Study on the Addition of ASA404 to Docetaxel in CRMPC for metastatic prostate cancer http://bit.ly/byPfMF
Sign In " Clinical Cancer Research
clincancerres.aacrjournals.org — “Sign In " Clinical Cancer Research” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on May 7, 2010 at 1:29 pm By:
Focused on Health Health Organization
Yet another reason to eat broccoli: Research suggests it fights breast cancer: http://bit.ly/al7QKl
Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells " Clinical Cancer Research
clincancerres.aacrjournals.org — “Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells " Clinical Cancer Research” View full resource at clincancerres.aacrjournals.org
Most Recently Shared on May 4, 2010 at 6:35 pm By:
Dr. Susan Beck CAM, Nutritionist, PhD, Acupuncturist, and Doctor
Broccoli Sprouts Inhibit Breast Cancer Stem Cells - http://bit.ly/broccoliandcancer
